ProQR Therapeutics N.V (PRQR) Cash & Current Investments: 2021-2025
Historic Cash & Current Investments for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $125,293.
- ProQR Therapeutics N.V's Cash & Current Investments rose 27.55% to $125,293 in Q3 2025 from the same period last year, while for Sep 2025 it was $326.6 million, marking a year-over-year increase of 37.27%. This contributed to the annual value of $159.7 million for FY2024, which is 24.11% up from last year.
- Latest data reveals that ProQR Therapeutics N.V reported Cash & Current Investments of $125,293 as of Q3 2025, which was down 99.93% from $169.1 million recorded in Q2 2025.
- In the past 5 years, ProQR Therapeutics N.V's Cash & Current Investments ranged from a high of $219.1 million in Q4 2021 and a low of $93,527 during Q1 2024.
- Over the past 3 years, ProQR Therapeutics N.V's median Cash & Current Investments value was $128.0 million (recorded in 2023), while the average stood at $91.5 million.
- In the last 5 years, ProQR Therapeutics N.V's Cash & Current Investments plummeted by 99.94% in 2024 and then spiked by 167,937.07% in 2025.
- Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Cash & Current Investments stood at $219.1 million in 2021, then plummeted by 55.28% to $98.0 million in 2022, then skyrocketed by 30.59% to $128.0 million in 2023, then slumped by 99.87% to $160,157 in 2024, then rose by 27.55% to $125,293 in 2025.
- Its last three reported values are $125,293 in Q3 2025, $169.1 million for Q2 2025, and $157.2 million during Q1 2025.